Novel associations of nonstructural Loci with paraoxonase activity.

Journal of Lipids
Ellen E QuillenM C Mahaney

Abstract

The high-density-lipoprotein-(HDL-) associated esterase paraoxonase 1 (PON1) is a likely contributor to the antioxidant and antiatherosclerotic capabilities of HDL. Two nonsynonymous mutations in the structural gene, PON1, have been associated with variation in activity levels, but substantial interindividual differences remain unexplained and are greatest for substrates other than the eponymous paraoxon. PON1 activity levels were measured for three substrates-organophosphate paraoxon, arylester phenyl acetate, and lactone dihydrocoumarin-in 767 Mexican American individuals from San Antonio, Texas. Genetic influences on activity levels for each substrate were evaluated by association with approximately one million single nucleotide polymorphism (SNPs) while conditioning on PON1 genotypes. Significant associations were detected at five loci including regions on chromosomes 4 and 17 known to be associated with atherosclerosis and lipoprotein regulation and loci on chromosome 3 that regulate ubiquitous transcription factors. These loci explain 7.8% of variation in PON1 activity with lactone as a substrate, 5.6% with the arylester, and 3.0% with paraoxon. In light of the potential importance of PON1 in preventing cardiovascular dis...Continue Reading

References

Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
Jan 1, 1993·Nature Genetics·R HumbertC E Furlong
Feb 1, 1997·Mammalian Genome : Official Journal of the International Mammalian Genome Society·R SztrolovicsG A Mitchell
May 23, 1998·American Journal of Human Genetics·L Almasy, J Blangero
Jan 14, 2000·Pharmacogenetics·R J Richter, C E Furlong
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·I Leviev, R W James
Nov 25, 2000·Metabolism: Clinical and Experimental·M InoueK Hashimoto
May 4, 2001·American Journal of Human Genetics·V H BrophyC E Furlong
Jun 27, 2001·American Journal of Medical Genetics·L SánchezE Coto
Oct 11, 2001·American Journal of Human Genetics·H H GöringJ Blangero
Jul 12, 2002·European Archives of Psychiatry and Clinical Neuroscience·György ParaghIstván Degrell
May 21, 2003·Circulation·Bharti MacknessMichael Mackness
Jun 7, 2003·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Stefano BiasioliAntonio Fasolin
Dec 13, 2003·Journal of Endocrinological Investigation·F AziziM Arabi
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Sep 15, 2004·Toxicology and Applied Pharmacology·Richard C ZangarSeema Verma
Sep 16, 2004·Journal of Human Genetics·Elias Zintzaras, Georgios M Hadjigeorgiou
Sep 30, 2004·Free Radical Biology & Medicine·Michael Aviram, Mira Rosenblat
Feb 9, 2005·Hypertension·Giuseppe BianchiJan A Staessen
Feb 18, 2005·Journal of Hypertension·Chiara LanzaniPaolo Manunta
Mar 16, 2005·BMC Bioinformatics·Euan A AdieBen S Pickard
Apr 19, 2005·Journal of Lipid Research·David L RainwaterJohn L Vandeberg
Apr 21, 2005·Kidney International·Michael S WolinSachin A Gupte
Mar 7, 2006·The Journal of Biological Chemistry·Shallee PageAndré Bensadoun
Jun 8, 2006·Annual Review of Biochemistry·Ronald J A Wanders, Hans R Waterham
Oct 31, 2006·FEBS Letters·Rachele ArrigoniNicole Schreiber-Agus
Nov 18, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Mitsuru ShimamuraIichiro Shimomura
Dec 28, 2006·Journal of Vascular Research·Sawako HatsudaYoshiki Nishizawa
Jan 16, 2007·Human Biology·Deidre A WinnierMichael C Mahaney
Jan 16, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tracy C DelozierJoyce A Goldstein
Apr 17, 2007·Digestive Diseases and Sciences·Amir KarbanRaanan Shamir
Sep 18, 2007·Nature Genetics·Harald H H GöringJohn Blangero

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

SUSPECTS
DAVID
SOLAR ( Sequential Oligogenic Linkage Analysis Routines )
Database for Annotation , Visualization , and Integrated Disco...
PEDSYS routine INFER
Haploview

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.